Pendred syndrome among patients with congenital hypothyroidism detected by neonatal screening: identification of two novel PDS/SLC26A4 mutations
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články
- MeSH
- dítě MeSH
- erytrocyty - protein 1 vyměňující anionty genetika MeSH
- kongenitální hypotyreóza komplikace diagnóza genetika MeSH
- lidé MeSH
- mladiství MeSH
- mutace MeSH
- novorozenec MeSH
- novorozenecký screening metody MeSH
- percepční nedoslýchavost komplikace diagnóza genetika MeSH
- rodokmen MeSH
- syndrom MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- novorozenec MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- erytrocyty - protein 1 vyměňující anionty MeSH
- SLC4A1 protein, human MeSH Prohlížeč
Pendred syndrome is an autosomal recessive disorder characterised by sensorineural hearing loss and thyroid dyshormonogenesis. It is caused by mutations in the PDS/SLC26A4 gene (OMIM 605646) encoding for pendrin. Hypothyroidism in Pendred syndrome can be--although rarely--present from birth and therefore diagnosed by neonatal screening. The aim of our study was to identify patients with Pendred syndrome among a historical cohort of patients with congenital hypothyroidism (CH) identified by neonatal screening, and to find their mutations in the PDS/SLC26A4 gene. We investigated 197 Czech Caucasian children with CH detected by the neonatal screening between the years 1985 and 2005. The clinical diagnosis of Pendred syndrome was based on the laboratory and sonographic signs of thyroid dyshormonogenesis in association with sensorineural hearing loss. In subjects clinically diagnosed with Pendred syndrome, we sequenced all exons and exon-intron boundaries of the PDS/SLC26A4 gene. Hearing loss was present in 10/197 children with screening-detected CH. Of these, three fulfilled the diagnostic criteria of Pendred syndrome. Two patients were compound heterozygotes for PDS/SLC26A4 mutations: patient 1 carried c.2089+1G>A / c.3G>C and patient 2 carried p.Tyr530His / p.Val422Asp. Two of the four identified mutations were novel (c.3G>C in patient 1 and p.Val422Asp in patient 2). The third patient was free of mutations in the PDS/SLC26A4 gene, representing a phenocopy. In conclusion, our results indicate the rarity of Pendred syndrome as a cause of CH. The identification of two novel mutations expands the spectrum of mutations in the PDS/SLC26A4 gene and emphasizes their marked allelic heterogeneity.
Zobrazit více v PubMed
J Clin Invest. 1992 Oct;90(4):1200-4 PubMed
Laryngoscope. 1978 May;88(5):723-8 PubMed
Nat Genet. 1999 Apr;21(4):440-3 PubMed
Audiology. 1983;22(4):404-9 PubMed
Clin Genet. 2004 Oct;66(4):333-40 PubMed
Laryngoscope. 1979 Oct;89(10 Pt 2 Suppl 19):1-25 PubMed
Nat Genet. 1997 Dec;17(4):411-22 PubMed
Hum Mutat. 1998;11(1):1-3 PubMed
Clin Genet. 2004 Aug;66(2):152-7 PubMed
J Clin Endocrinol Metab. 2004 Nov;89(11):5347-51 PubMed
J Med Genet. 1996 Dec;33(12):1037-40 PubMed
QJM. 1997 Jul;90(7):443-7 PubMed
J Clin Invest. 1967 Nov;46(11):1828-39 PubMed
Endocrinology. 2000 Feb;141(2):839-45 PubMed
Acta Otolaryngol. 1981 Nov-Dec;92(5-6):469-80 PubMed
Nat Genet. 1996 Apr;12(4):424-6 PubMed
Clin Radiol. 1998 Apr;53(4):268-73 PubMed
Nat Genet. 1996 Apr;12(4):421-3 PubMed
Ann Hum Genet. 1965 Mar;28:201-49 PubMed
J Clin Endocrinol Metab. 1991 Feb;72(2):471-6 PubMed
Hum Mol Genet. 1998 Jul;7(7):1105-12 PubMed
J Med Genet. 1992 Aug;29(8):521-6 PubMed
Trends Genet. 1999 Jun;15(6):207-11 PubMed
Arch Otolaryngol. 1962 Nov;76:401-6 PubMed
Hum Mol Genet. 2000 Jul 1;9(11):1709-15 PubMed
Curr Opin Pediatr. 2001 Aug;13(4):364-72 PubMed
Eur J Endocrinol. 2007 May;156(5):521-9 PubMed
J Med Genet. 1999 Aug;36(8):595-8 PubMed
Clin Endocrinol (Oxf). 2005 Apr;62(4):444-8 PubMed
J Clin Endocrinol Metab. 2003 Jun;88(6):2916-21 PubMed
J Assoc Res Otolaryngol. 2003 Sep;4(3):394-404 PubMed
J Paediatr Child Health. 1992 Oct;28(5):398-401 PubMed
OMIM
605646